Susceptibility of motile and cystic forms of Borrelia burgdorferi IQ ranitidine bismuth citrate

International Microbiology

Volumn 4, Issue 4, 2001, Pages 209-215

  Brorson, Oystein ^a   Brorson, Sverrc Henning ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Vestfold Sentralsykehus ^*  (Norway)

Author keywords

Bismuth compounds; Borrclia burgdorferi; Cystic forms; Spheroplasts; Spirochetes

Indexed keywords

ANTIINFECTIVE AGENT; BISMUTH; DRUG DERIVATIVE; RANITIDINE; RANITIDINE BISMUTH CITRATE;

ARTICLE; BORRELIA BURGDORFERI; DRUG EFFECT; ELECTRON MICROSCOPY; HUMAN; MICROBIOLOGICAL EXAMINATION; MOVEMENT (PHYSIOLOGY); PHYSIOLOGY; TIME; ULTRASTRUCTURE;

ANTI-BACTERIAL AGENTS; BISMUTH; BORRELIA BURGDORFERI; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; MOVEMENT; RANITIDINE; TIME FACTORS;

EID: 0035756181     PISSN: 11396709     EISSN: None     Source Type: Journal    
DOI: 10.1007/S10123-001-0039-7     Document Type: Article

References (44)

1. Alban PS, Johnson PW, Nelson DR (2000) Serum-starvationinduced changes in protein synthesis and morphology of Borrelia burgdorferi. Microbiology 146:119-127
2. Andersen AP, Elliott DA, Lawson M, Barland P, Hatcher VB, Puszkin EG (1997) Growth and morphological transformation of Helicobacter pylori in broth media. J Clin Microbiol 35:2918-2922
3. Asbrink E, Hovmark A, Hederstedt B (1984) The spirochetal etiology of acrodermatitis chronica atropicans Herxheimer. Acta Derm Venereol 64:291-295
4. Bierer DW (1990) Bismuth subsalicylate: history, chemistry, and safety. Rev Infect Dis 12:3-8
5. Brorson 0, Brorson SH (1997). Transformation of cystic forms of Borrelia burgdorferi to normal mobile spirochetes. Infection 25:240-246
6. Brorson 0, Brorson SH (1998) A rapid method for generating cystic forms of Borrelia burgdorferi and their reversal to motile spirochetes. Acta Pathol Microbiol Immunol Scand 106: 1131-1141
7. Brorson 0, Brorson SH (1998) In vitro conversion of Barrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection 26:144-150
8. Brorson 0, Brorson SH (1999) An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole. Acta Pathol Microbiol Immunol Scand 107:566-576
9. Brorson SH, Skjorten F (1995) Mechanism for antigen detection on deplasticized epoxy sections. Micron 26:301-310
10. Brorson SH, Strom EH, Skjorten F (1997) Immunoelectron microscopy on epoxy sections without deplasticizing to detect glomerular immunoglobulin and complement deposits in renal diseases. Acta Pathol Microbiol Immunol Scand 105:139149
11. DuPont HL, Sullivan P, Pickering LK, Haynes G, Ackerman PB (1977). Symptomatic treatment of diarrhoea with bismuth subsalicylate among students attending a Mexican university. Gastroenterology 73:715-18
12. Eberhard! R, Kasper G (1990) Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer. Rev Infect Dis 12 [Suppl 1]:115-119
13. Ericsson CD, Tannenbaum C, Charles TT (1990) Antisecretory and antiinflammatory properties of bismuth subsalicylate. Rev Infect Dis 12 [Suppl 1]:16-20
14. Figueroa-Quintanilla D, Salasar-Lindo E, Bradley Sack R, Leon-Barua R, Sarabia-Arche S, Campos-Sanchez M, Eyzaguirre-Maccan E (1993) A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl JMed 328:1653-1658
15. Fried MD, Abel M, Pietrucha D, Kuo YH, Bal A (1999) The spectrum of gastrointestinal manifestation in children and adolescents with Lyme disease. J Spirochete Tick-Borne Dis 6:89-93
16. Goellner MH, Agger WA, Burgess JH, Duray PH (1988) Hepatitis due to recurrent Lyme disease. Ann Intern Med 108:707-708
17. Hulinska D, Bartäk P, Hercogovâ J, Hancil J, Basta J, Schramlovâ J (1994) Electron microscopy of Langerhans cells and Borrelia burgdorferi in Lyme disease patients. Zentralbl Bakteriol 280:348-359
18. Kersten A, Poitschek S, Rauch S, Aberer E (1995) Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob Agents Chemother 39: 1127-1133
19. Lambert JR, Midolo P (1997) The actions of bismuth in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 11:27-33
20. Lambert JR, Way DJ, King RG, Eaves ER, Lianeas K, Wan A (1989) De-Nol vs pepto-bismol-bismuth pharmacokinetics in the human gastric mucosa. Gastroenterology 96:A284
21. Lambert JR, Arena G, Nicholson L, Onishi N, Finlay M, Renwick J (1994) Ranitidine bismuth citrate: systemic and local gastric single dose pharmacokinetics in Helicobacter pylori positive and negative subjects. Gastroenterology 106:A120
22. Lawrence C, Lipton RB, Lowy FD, Coyle PK (1995) Seronegative chronic relapsing neuroborreliose. Eur Neurol 35:113-117
23. Liegner KB, Duray P, Agricola M, Rosenkilde C, Yannuzzi LA, Ziska M, Tilton RC, Hulinska D, Hubbard J, Fallen BA (1997) Lyme disease and the clinical spectrum of antibiotic responsive chronic meningoencefalomyelitides. J Spirochete Tick-Borne Dis 4:61-73
24. Lim LCL, Liu YF, Schell K, Lovrich SD, Callister SM, Schell RF (1994) Detection of borreliacidal antibody by using acridine oranee and flow cytometry. Clin Diagn Lab Immunol 1:44-50
25. Luft BJ, Steinman CR, Neimark HC, Muralidhar B, Rush T, Finkel MF, Kunkel M, Dattwyler RJ (1992) Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. J Am Med Assoc 267:1364-1367
26. Ma Y, Seiler KP, Tai KF, Yang L, Woods M, Weis JJ (1994) Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect Immun 62:3663-3671
27. MacDonald AB (1988) Concurrent neocortical borreliosis and Alzheimer's disease. Ann NY Acad Sei 539:468-4470
28. Mahony DE, Lim-Morrison S, Bryden L, Faulkner G, Hoffman PS, Agocs L, Briand GG, Burford N, Maguire H (1999) Antimicrobial activities of synthetic bismuth compounds against Clostridium difficile. Antimicrob Aeents Chemother 43:582-588
29. McCarthy LR, Senne JE (1980) Evaluation of acridine orange stain for detection of microorganisms in blood cultures. J Clin Microbiol 11:281-285
30. Midolo PD, Lambert JR, Kerr TG, Tee W (1999) In vitro synergy between ranitidine bismuth citrate and tetracycline or claritromycin against resistant strains of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 18:832-834
31. Miliotis MD (1991) Acridine orange stain for determining intracellular enteropathogens in HeLa cells. J Clin Microbiol 29:830-831
32. Oksi J, Mertsola J, Reunanen M, Marjameki M, Viljanen MK (1994) Subacute multiple-site osteomyelitis caused by Borrelia burgdorferi. Clin Infect Dis 19:891-896
33. Oksi J, Kalimo H, Marttila RJ, Marjameki M, Sonninen P, Nikoskelainen J, Viljanen MK (1996) Inflammatory brain changes in Lyme borreliosis. A report on three patients and review ofliterature. Brain 119:2143-2154
34. Oksi J, Nikoskelainen J, Viljanen MK (1998) Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis. Eur J Clin Microbiol Infect Dis 17:715-719
35. Petrovic M, Vogelaers D, Van Renterghem L, Carton D, Reuck J de, Afschrift M (1998) Lyme borreliosis - a review of the late stage and treatment of four cases. Acta Clin Belg 53:178-183
36. Pollack RJ, Telford SR, Spielman A (1993) Standardisation of medium for culturing Lyme disease spirochetes. J Clin Microbiol 31:1251-1255
37. Preac-Mursic V, Weber K, Pfister HW, Wilske B, Gross B, Baumann A, Prokop J (1989) Survival of Borrelia burgdorferi spheroplast-L-form variants. Infection 24:218-226
38. Preac Mursic V, Marget W, Busch U, Pleterski Rigler D, Hagl S (1996) Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis. Infection 25:9-16
39. Preac Mursic V, Wanner G, Réinhardt S, Wilske B, Busch U, Marget W (1996) Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants. Infection 24:218-226
40. Schaller M, Neubert U (1994) Ultrastructure of Borrelia burgdorferi after exposure to benzypenicillin. Infection 22:401406
41. Steere AC (1989) Lyme disease. N Enel J Med 321:586-596
42. Stratton CW, Warner RR, Goudron PE, Lilly NA (1999) Bismuth-mediated disruption of the glycocalyx-cell wall of Heliobacter pylori: ultrastructural evidence for a mechanism of action for bismuth salts. J Antimicrob Chemother 43:659-666
43. Vo/î F (1942) Die Geschlectskrankheiten. In: Gundel M (ed) Die anstreckenden Kranheiten. Thieme, Leipzig, pp 328-344
44. Woolen MR, Mudor VR, Mclntyre TM, Weis JJ (I996) Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-kB and inflammatory activation in human endothelial cells. J Immunol 157:4584-4590